Načítá se...
Treatment of NRAS-Mutant Melanoma
NRAS mutations in codons 12, 13, and 61 arise in 15–20 % of all melanomas. These alterations have been associated with aggressive clinical behavior and a poor prognosis. Until recently, there has been a paucity of promising genetically targeted therapy approaches for NRAS-mutant melanoma (and RAS-mu...
Uloženo v:
| Vydáno v: | Curr Treat Options Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830486/ https://ncbi.nlm.nih.gov/pubmed/25796376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-015-0330-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|